ストックスクリーナーアプリを入手
0.90
12.50%
0.10
前日終値:
$0.80
開ける：
$0.75
24時間の取引高:
4,336
Relative Volume:
11.08
時価総額：
$N/A
収益：
$257.55M
当期純損益:
$11.95M
株価収益率:
0.989
EPS:
0.91
ネットキャッシュフロー:
$-9.39M
1週間 パフォーマンス:
+16.07%
1か月 パフォーマンス:
-76.15%
6か月 パフォーマンス:
-81.21%
1年 パフォーマンス:
-93.26%
1日の値動き範囲:
$0.75
$0.90
1週間の範囲:
$0.66
$0.90
52週間の値動き範囲:
$0.66
$0.90
Eagle Pharmaceuticals Inc Stock (EGRX) Company Profile
EGRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
EGRX
Eagle Pharmaceuticals Inc
|
0.90 | 0 | 257.55M | 11.95M | -9.39M | 0.91 |
|
ZTS
Zoetis Inc
|
171.38 | 77.44B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.56 | 43.22B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.53 | 42.94B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.85 | 18.94B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
127.01 | 13.51B | 612.78M | -86.37M | -62.91M | -0.87 |
Eagle Pharmaceuticals Inc Stock (EGRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2018-11-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-31 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2018-03-21 | 繰り返されました | Mizuho | Underperform |
| 2017-11-09 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-09-06 | 繰り返されました | Mizuho | Underperform |
| 2017-07-27 | 繰り返されました | Mizuho | Underperform |
| 2017-07-27 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-05-09 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-01-09 | ダウングレード | Mizuho | Neutral → Underperform |
| 2016-11-16 | ダウングレード | Mizuho | Buy → Neutral |
| 2016-11-03 | アップグレード | Mizuho | Neutral → Buy |
| 2016-11-03 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2016-10-26 | 繰り返されました | Mizuho | Buy |
| 2016-08-16 | 繰り返されました | Mizuho | Neutral |
| 2016-06-20 | ダウングレード | Mizuho | Buy → Neutral |
| 2016-05-10 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2016-03-18 | 繰り返されました | Mizuho | Buy |
| 2016-02-26 | 繰り返されました | Mizuho | Buy |
| 2015-12-09 | 開始されました | Mizuho | Buy |
| 2015-07-29 | 繰り返されました | Piper Jaffray | Overweight |
すべてを表示
Eagle Pharmaceuticals Inc (EGRX) 最新ニュース
EGRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Eagle Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated by Analysts at StockNews.com - Defense World
Eagle Pharmaceuticals, Inc. Enters Third Amended and Restated Credit Agreement - Marketscreener.com
StockNews.com Begins Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX) - Defense World
Eagle Pharmaceuticals (NASDAQ:EGRX) Coverage Initiated at StockNews.com - Defense World
Jane Street Group LLC Makes New Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09% - MSN
Antiemetics Drugs Market Size & Share Report, 2024 – 2032 - Global Market Insights
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com - Defense World
Last Week's Biggest Stock Movers: Eagle, Noodles & Co. - AOL
Eagle Pharmaceuticals Enters Into Settlement Agreement With Dr. Reddy's Laboratories on Leukemia Drug - Marketscreener.com
Eagle Pharmaceuticals : to Present at Jefferies Virtual Healthcare Conference 2021 - Marketscreener.com
Eagle Pharmaceuticals Amends Rights Agreement with Equiniti Trust Company - Defense World
Eagle Pharmaceuticals amends rights agreement - Investing.com
Eagle Pharmaceuticals amends rights agreement By Investing.com - Investing.com Nigeria
Eagle Pharmaceuticals Dismisses Ernst & Young LLP as Independent Registered Public Accounting Firm - Defense World
Eagle Pharmaceuticals switches to BDO after Ernst & Young dismissal - Investing.com
Eagle Pharmaceuticals switches to BDO after Ernst & Young dismissal By Investing.com - Investing.com UK
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceutica - GuruFocus.com
Eagle Pharma Founder Sues Company to Recoup Cost of SEC Investigation - Law.com
Ex-Pharma CEO Demands Legal Fees For SEC Probe - Law360
Eagle Pharmaceuticals names Christopher Krawtschuk as CFO - MSN
Eagle Pharmaceuticals to Delist from Nasdaq By Investing.com - Investing.com Australia
Eagle Pharmaceuticals, Inc. Announces Executive Changes - Marketscreener.com
Eagle Pharmaceuticals to Delist from Nasdaq - Investing.com India
Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration - The Manila Times
Eagle Pharmaceuticals to Complete Nasdaq Delisting After Trading Suspension | EGRX Stock News - StockTitan
Eagle Pharmaceuticals (NASDAQ:EGRX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Citigroup Inc's Strategic Reduction in Eagle Pharmaceuticals Inc Shares - GuruFocus.com
Creative Planning Makes New $59,000 Investment in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) - Defense World
Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial OfficerWOODCLIFF LAKE, N.J. — November 12, 2024 — Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) recently announced the appointment of Christopher Krawtschuk as the Chief - Defense World
Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer - The Manila Times
Eagle Pharmaceuticals, Inc. Announces Chief Financial Officer Changes - Marketscreener.com
Some Major Key Players In The Heparin-Induced Thrombocytopenia (HIT) Treatment Market: - InsightAce Analytic
Nantahala Capital Management Reduces Stake in Eagle Pharmaceuticals - GuruFocus.com
Eagle Pharmaceuticals to Develop Dantrolene Sodium for Potential Treatment of Alzheimer’S Disease in Collaboration with University of Pennsylvania - Marketscreener.com
Eagle Pharmaceuticals Adopts Stockholder Rights Plan to Protect Shareholders’ Interests - Defense World
Union Square Park Capital Management, LLC Increases Stake in Eagle Pharmaceuticals Inc - GuruFocus.com
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan - The Manila Times
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle - GlobeNewswire
Pemetrexed Market Is Booming Worldwide 2024-2031 | Stada - openPR
Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - ForexTV.com
Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information - GlobeNewswire Inc.
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by Analysts at StockNews.com - Defense World
Global Antiemetics Drugs Market to Exhibit Growth at a CAGR of ~6% by 2030 | DelveInsight - GlobeNewswire
Eagle Pharmaceuticals Inc (EGRX) 財務データ
収益
当期純利益
現金流量
EPS
0.57%
3.84%
大文字化:
|
ボリューム (24 時間):